                                  DC REGULATIONS

THERAPEUTIC USE OF PSYCHOTROPIC MEDICATIONS (ยง 29-6264)

6264.1. If psychotropic medication is prescribed, the facility shall cooperate
   with the contracting entity and, where applicable, the CSSD to obtain a
   written report from the prescribing physician detailing:
   
   
   
   (a)	The type of medication;
   
   
   
   (b)	The dosage;
   
   
   
   (c)	The necessity for the medication;
   
   
   
   (d) The resident&#8217;s other medications and the effect of their
   interaction;
   
   
   
   (e)	The staff monitoring requirements, if any;
   
   
   
   (f)	Potential side effects;
   
   
   
   (g)	The next scheduled clinical meeting; and
   
   
   
   (h)	A current therapeutic treatment plan or behavioral management plan.

   6264.2. The facility shall cooperate with the contracting entity and, where
   applicable, the CSSD to obtain written consent from the resident&#8217;s
   parent(s) or guardian(s), or court order, before administering psychotropic
   medications.

   6264.3. The facility shall document the prescription and administration of
   medication, and notify attending physicians of, and record, significant
   changes in a resident&#8217;s behavior or health.
   
   
   
   	SOURCE: Final Rulemaking published at 48 DCR 8675, 8729 (September 21, 2001).
